3-n-butylphthalide has been researched along with Neurodegenerative Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Cai, H; Ge, J; He, X; Xie, T; Yao, C; Ye, XY; Zhong, Z; Zhu, J | 1 |
| Jia, JP; Li, BQ; Li, FY; Li, Y; Quan, MN; Xu, LZ; Zhang, H; Zhao, Y | 1 |
| Feng, Y; Huang, L; Ma, F; Peng, Y; Wang, S; Wang, X; Xing, C; Zhang, Y | 1 |
2 review(s) available for 3-n-butylphthalide and Neurodegenerative Diseases
| Article | Year |
|---|---|
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification.
Topics: Biological Products; Blood-Brain Barrier; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Parkinson Disease | 2022 |
From stroke to neurodegenerative diseases: The multi-target neuroprotective effects of 3-n-butylphthalide and its derivatives.
Topics: Animals; Benzofurans; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Stroke | 2018 |
1 other study(ies) available for 3-n-butylphthalide and Neurodegenerative Diseases
| Article | Year |
|---|---|
CaMKIIα Signaling Is Required for the Neuroprotective Effects of Dl-3-n-Butylphthalide in Alzheimer's Disease.
Topics: Alzheimer Disease; Benzofurans; Humans; Neurodegenerative Diseases; Neuroprotective Agents | 2022 |